References
- Rondeau, E., Solal-Celigny, P., Dhermy, D., Vrodans, M., Brousse, N., Bernard, J.E and Boivin, R (1983) “Immune disorders in agnogenic myeloid metaplasia: relation to myelofibrosis”, Br. J. Haematol. 53, 467–475.
- Gordon, B.R., Coleman, M., Kohen, P. and Day, N.K. (1981) “Immunologic abnormalities in myelofibrosis with activation of the complement system”, Blood 58, 904–910.
- Jacobson, R.S., Salo, A. and Fialkow, P.S. (1978) “Agnogenic myeloid metaplasia: a donal proliferation of hematopoietic stem cells with secondary myelofibrosis”, Blood 51, 189–194.
- Kahn, A., Bernard, J.F., Cottreau, D., Marie, J. and Boivin, P. (1975) “Gd(—) Abrami: a deficient G-6-PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis”, Humangenetik 30, 41–46.
- Bernabei, P.A., Arcangeli, A., Casini, M., Grossi, A., Padovani, R. and Rossi Ferrini, P. (1986) “Platelet-derived growth factor(s) mitogenic activity in patients with myeloproliferative disease”, Br. J. Haematol. 63, 353–357.
- Selreos, O., Skifvars, B. and Usastrjema, C. (1973) “Immunological deficiency in myelofibrosis”, Scand. J. Haematol. 11, 307–313.
- Vellenga, E., Mulder, N. and The, T. (1982) “A study of the cellular and humoral immune response in patients with myelofibrosis”, Clin. Lab. Haematol. 4, 307–316.
- Groopman, J.E. (1980) “The pathogenesis of myelofibrosis in myeloproliferative disorders”, Ann. Int. Med. 92, 857–858.
- Von Knorring, J., Selroous, O.W. and Wegelius, O. (1974) “Myeloid metaplasia in disseminated vascular disease”, Acta Med. Scand. 195, 137.
- Ben-Chetrit, E., Gross, D.J. and Ikon, E. (1983) “The association between autoimmunity and agnogenic myeloid metaplasia”, Scand. J. Haematol. 31, 410.
- Plotz, P.H., Dalakas, M., Leff, R.L., Love, L.A., Miller, F.W. and Cronin, M.E. (1989) “Current concepts in the idiopathic inflammatory myopathies; polymyositis, dermatomyositis and related disorders”, Ann. Int. Med. 111, 143–157.
- Dalakas, M.C. (1991) “Polymyositis, dermatomyositis, and inclusion-body myositis”, N. Engl. J. Med. 325, 1487–1498.
- Sigurgeirsson, B., Lindelöf, B., Edhag, O. and Allander, E. (1992) “Risk of cancer in patients with dermatomyositis or polymyositis”, N. Engl. J. Med. 326(6), 363–367.